Blocking or potentiating IL-10 signalization by artificially evolved non-antibody binders such as H33 could be an important component of the treatment of inflammatory, malignant and autoimmune diseases in which IL-10 plays a role. The gene discussed is IL10; the disease is autoimmune disease.